1. China Stocks

  2. •

    Health technology

  3. •

    Biotechnology
EVOPOINT BIOSCIENCES CO LTD

EVOPOINT BIOSCIENCES CO LTD

SSSE:688837
37.71
CNY
-2.08
(-5.23%)
-0.05EPS
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
0.06
- -
- -
2.54
Basic EPS, GAAP
-1.42
-1.25
-1.05
0.55
Free Cash Flow per Basic Share
-1.78
-1.35
-1.09
0.31
Dividend per Share
0.02
0.04
0.04
0.07
Book Value per Share
1.41
1.7
0.98
1.91
Tangible Book Value per Share
1.38
1.67
0.96
1.88
Basic Weighted Avg Shares
326
342
368
368
Sales/Revenue/Turnover
20
- -
- -
935
Operating Margin (%)
-2,645.69
- -
- -
22.75
Depreciation Expense
15
18
26
40
Net Income, GAAP
-463
-427
-386
203
Effective Tax Rate (%)
- -
- -
- -
31.4
Profit Margin (%)
-2,372.47
- -
- -
21.66
Working Capital
276
361
116
603
LT Debt
286
345
398
728
Total Equity
459
579
359
703
Return on Invested Capital (%)
- -
- -
- -
19.16
Return on Capital (%)
- -
- -
- -
17.64
Return on Common Equity (%)
- -
-82.22
-82.26
38.13

Capital Structure

CNY

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

CNY

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
95.58%
Free Cash Flow
- -
- -
-128.95%
Net Income, GAAP
- -
- -
-152.48%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
47.39%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
935
2026
4
172
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-1.05
2025
-0.23
-0.63
- -
- -
0.55
2026
-0.34
-0.05
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.04
2025
- -
- -
- -
- -
0.07
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Mei Jie Le
Full Time Employees
362
Sector
Health technology
Industry
Biotechnology
Address
Building 22, Area B, 218 Sangtian Street, Suzhou Industrial Park Suzhou JS China 215000
IPO Date
Sep 16, 2026
Website
evopointbio.com
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Amgen Inc. (NASDAQ:AMGN)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Novavax, Inc. (NASDAQ:NVAX)
10x Genomics, Inc. (NASDAQ:TXG)
Business
Evopoint Bioscience Co., Ltd. operates as a biopharmaceutical company. It produces inhibitors, diagnostic reagents, and other products. The company was founded by Mei Jie Le and Hong Han Hu on May 17, 2017 and is headquartered in Suzhou, China.